Spero Therapeutics, Inc. (SPRO) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は GSK PLC 9,190,606 株保有. その他の主要保有者には Aquilo Capital, L.P. および Aquilo Capital Management, LLC.
過去12ヶ月間にインサイダーは 18 件の取引を実施 SPRO 株式 — 11 件の買い (評価額 $1.42M) および 7 件の売り (評価額 $335.28K). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.
SPRO インサイダー保有状況
最大保有者
GSK PLC
9,190,606 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
Gsk Plc |
Director |
9,190,606 |
2022-11-14 |
|
| 2 |
Aquilo Capital, L.p. |
Director |
5,321,231 |
2022-04-28 |
|
| 3 |
Aquilo Capital Management, Llc |
10 Percent Owner |
3,419,435 |
2022-09-26 |
|
| 4 |
Glaxosmithkline Plc |
10 Percent Owner |
1,934,006 |
2018-07-17 |
|
| 5 |
Shukla Sath |
CEO & President |
1,892,216 |
2025-02-05 |
|
| 6 |
Graham Holdings Co |
10 Percent Owner |
1,428,094 |
2015-11-02 |
|
| 7 |
Rajavelu Esther |
See Remarks |
1,012,091 |
2026-02-09 |
|
| 8 |
Hamed Kamal |
Chief Medical Officer |
816,192 |
2024-02-05 |
|
| 9 |
Keutzer Timothy |
Chief Operating Officer |
742,506 |
2026-02-09 |
|
| 10 |
Mahadevia Ankit |
Director |
703,294 |
2025-09-03 |
|
| 11 |
Joseph Tamara L |
Chief Legal Officer |
562,521 |
2024-02-05 |
|
| 12 |
Deshpande Milind |
Director |
91,454 |
2025-06-16 |
|
| 13 |
Pottage John C Jr |
Director |
75,000 |
2025-06-16 |
|
| 14 |
Vink Patrick V.j.j. |
Director |
75,000 |
2025-06-16 |
|
| 15 |
Tregoning Kathleen |
Director |
75,000 |
2025-06-16 |
|
| 16 |
Smith Cynthia |
Director |
75,000 |
2025-06-16 |
|
| 17 |
Jackson Scott Thomas |
Director |
75,000 |
2025-06-16 |
|
| 18 |
Thomas Frank E |
Director |
75,000 |
2025-06-16 |
|
| 19 |
Sendek Joel |
Chief Financial Officer |
65,000 |
2019-01-02 |
|
| 20 |
Larkin Cristina |
Chief Operating Officer |
53,190 |
2022-02-03 |
|
最近の取引 (過去12ヶ月)
| 日付 |
氏名 |
役職 |
種類 |
株数 |
株価 |
価値 |
| 2026-02-06 |
Rajavelu Esther |
See Remarks |
情報に基づく売り |
50,816 |
$2.36 |
$119.93K |
| 2026-02-06 |
Keutzer Timothy |
Chief Operating Officer |
情報に基づく売り |
18,652 |
$2.36 |
$44.02K |
| 2026-02-04 |
Keutzer Timothy |
Chief Operating Officer |
情報に基づく売り |
3,471 |
$2.24 |
$7.78K |
| 2026-02-03 |
Keutzer Timothy |
Chief Operating Officer |
情報に基づく売り |
24,224 |
$2.14 |
$51.84K |
| 2026-02-02 |
Keutzer Timothy |
Chief Operating Officer |
RSU 付与(制限付株式) |
137,000 |
$2.23 |
$305.51K |
| 2026-02-02 |
Rajavelu Esther |
See Remarks |
RSU 付与(制限付株式) |
498,000 |
$2.23 |
$1.11M |
| 2025-11-07 |
Rajavelu Esther |
See Remarks |
情報に基づく売り |
40,270 |
$2.37 |
$95.44K |
| 2025-08-28 |
Keutzer Timothy |
Chief Operating Officer |
情報に基づく売り |
1,695 |
$1.97 |
$3.34K |
| 2025-08-28 |
Mahadevia Ankit |
Director |
情報に基づく売り |
6,572 |
$1.97 |
$12.95K |
| 2025-06-12 |
Tregoning Kathleen |
Director |
RSU 付与(制限付株式) |
20,000 |
- |
- |
| 2025-06-12 |
Mahadevia Ankit |
Director |
RSU 付与(制限付株式) |
20,000 |
- |
- |
| 2025-06-12 |
Smith Cynthia |
Director |
RSU 付与(制限付株式) |
20,000 |
- |
- |
| 2025-06-12 |
Jackson Scott Thomas |
Director |
RSU 付与(制限付株式) |
20,000 |
- |
- |
| 2025-06-12 |
Vink Patrick V.j.j. |
Director |
RSU 付与(制限付株式) |
20,000 |
- |
- |
| 2025-06-12 |
Deshpande Milind |
Director |
RSU 付与(制限付株式) |
20,000 |
- |
- |
| 2025-06-12 |
Pottage John C Jr |
Director |
RSU 付与(制限付株式) |
20,000 |
- |
- |
| 2025-06-12 |
Thomas Frank E |
Director |
RSU 付与(制限付株式) |
20,000 |
- |
- |
| 2025-05-02 |
Rajavelu Esther |
See Remarks |
RSU 付与(制限付株式) |
185,000 |
- |
- |